Duke spin-out raises $7 million to advance gene therapy purification technology

A Durham biotech startup that spun out of Duke University has raised $7 million in seed funding to scale up its purification technology for biotherapeutics. Isolere Bio Inc. announced Wednesday it has raised $7 million in equity from lead investor Maryland-based venture capital firm Northpond Ventures. The funding will allow for development, scaling up and commercialization of the purification technology for adeno-associated viral vectors (AAV), which account for 40 percent of the viral vector…